Pfizer and BioNTech have received FDA Emergency Use Authorization (EUA) for a third booster dose of their COVID-19 vaccine that is broader than recommended last week by an advisory panel to the agency.
New tools and platforms to accelerate vaccine development and manufacturing are in high demand and short supply. InDevR’s VaxArray Platform is a microarray-based system for…
Two independent research teams have successfully regenerated mouse brain circuits in mice using neurons grown from rat stem cells.
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
And there are benefits of plant cell expression systems, notably their impact on the cost of goods sold (COGS).
A British-based cell therapy company is using smart operations to streamline its viral vector processing.
CMS proposed Medicare’s CGT reimbursement policy matches Medicaid’s sickle cell disease policy, forming a unified government approach.
Prodigiosin applications extend from manufacturing pigment and environmental-control agent to antibiotic and potential oncology drug.
Insilico Medicine is heading to the clinic with a treatment for methylthioadenosine phosphorylase (MTAP) deleted cancers.
New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate reductions for drug discovery.
The mini colons replicate both the physical structure and cellular diversity in the colon in both healthy and diseased states.
